• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CENTRAL LINE; CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CENTRAL LINE; CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS Back to Search Results
Patient Problem Unspecified Infection (1930)
Event Type  Injury  
Event Description
Pt reports they are currently in england and hospitalized due to central line infection (onset date unknown] and will have a new line placed.Date of admittance or current length of hospitalization is unknown.Unknown if md is aware.No further info, details or dates available.Iv remodulin pt.Reported to cvs/caremark by pt/caregiver.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CENTRAL LINE
Type of Device
CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS
MDR Report Key17887390
MDR Text Key325301233
Report NumberMW5146683
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)Y
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/05/2023
Patient Sequence Number1
Treatment
CREMITRAM ER; LETAIRIS; PUMP CADD LEGACY; REMODULIN MDV; STERILE DILUENT FOR REMODULIN
Patient Outcome(s) Hospitalization;
Patient SexFemale
-
-